Table 5 Overall survival
Arm A (BVZ + CAPE + RT) | Arm B (CAPE + RT) | |
|---|---|---|
Summary of events | ||
No of patients | 44 | 46 |
No of patients with event | 10 (22.73%) | 7 (15.22%) |
No of censored patients | 34 (77.27%) | 39 (84.78%) |
Lab | ||
Median (95% CI) | NA (NA, NA) | NA (NA, NA) |
25th–75th percentile | NA - NA | NA - NA |
Percent Survival (%, 95 CI) | ||
36 months | 88.64 (74.83, 95.11) | 95.65 (83.71, 98.89) |
60 months | 81.82 (66.92, 90.46) | 86.96 (73.25, 93.92) |
Kaplan-Meier model | ||
P-value (Log-rank) | 0.3350 | |
Cox Model | Hazard ratio (95% CI) | Cox Model P-value |
Arm A (BVZ + CAPE+RT) vs Arm B (CAPE+RT) | 1.6013 (0.6091, 4.2097) | 0.3397 |